249 related articles for article (PubMed ID: 21459133)
61. Antiangiogenic effects and mechanisms of trans-ethyl p-methoxycinnamate from Kaempferia galanga L.
He ZH; Yue GG; Lau CB; Ge W; But PP
J Agric Food Chem; 2012 Nov; 60(45):11309-17. PubMed ID: 23106130
[TBL] [Abstract][Full Text] [Related]
62. Secondary metabolites from Chamaedora tepejilote (Palmae) are active against Mycobacterium tuberculosis.
Jiménez A; Meckes M; Alvarez V; Torres J; Parra R
Phytother Res; 2005 Apr; 19(4):320-2. PubMed ID: 16041726
[TBL] [Abstract][Full Text] [Related]
63. Anti-tuberculosis neolignans from Piper regnellii.
Scodro RB; Pires CT; Carrara VS; Lemos CO; Cardozo-Filho L; Souza VA; Corrêa AG; Siqueira VL; Lonardoni MV; Cardoso RF; Cortez DA
Phytomedicine; 2013 May; 20(7):600-4. PubMed ID: 23474218
[TBL] [Abstract][Full Text] [Related]
64. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
Patel KN; Telvekar VN
Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490
[TBL] [Abstract][Full Text] [Related]
65. Resistance patterns of multidrug-resistant tuberculosis in Western Province, Papua New Guinea.
Simpson G; Coulter C; Weston J; Knight T; Carter R; Vincent S; Robertus L; Konstantinos A
Int J Tuberc Lung Dis; 2011 Apr; 15(4):551-2. PubMed ID: 21396218
[TBL] [Abstract][Full Text] [Related]
66. Antimycobacterial activity of methanolic plant extract of Artemisia capillaris containing ursolic acid and hydroquinone against Mycobacterium tuberculosis.
Jyoti MA; Nam KW; Jang WS; Kim YH; Kim SK; Lee BE; Song HY
J Infect Chemother; 2016 Apr; 22(4):200-8. PubMed ID: 26867795
[TBL] [Abstract][Full Text] [Related]
67. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Xu ZQ; Barrow WW; Suling WJ; Westbrook L; Barrow E; Lin YM; Flavin MT
Bioorg Med Chem; 2004 Mar; 12(5):1199-207. PubMed ID: 14980631
[TBL] [Abstract][Full Text] [Related]
68. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
69. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y
Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936
[TBL] [Abstract][Full Text] [Related]
70. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
Martins M; Viveiros M; Ramos J; Couto I; Molnar J; Boeree M; Amaral L
Int J Antimicrob Agents; 2009 May; 33(5):479-82. PubMed ID: 19155160
[TBL] [Abstract][Full Text] [Related]
71. Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae).
Jiménez-Arellanes A; Meckes M; Torres J; Luna-Herrera J
J Ethnopharmacol; 2007 May; 111(2):202-5. PubMed ID: 17236730
[TBL] [Abstract][Full Text] [Related]
72. [Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period].
Uçar E; Kiliç A; Ceyhan I; Yilmaz S; Kiliç S; Tarhan G; Simşek H; Güllü U; Başustaoğlu AC
Mikrobiyol Bul; 2010 Jan; 44(1):11-9. PubMed ID: 20455394
[TBL] [Abstract][Full Text] [Related]
73. Antimycobacterial screening of traditional medicinal plants using the microplate resazurin assay.
Webster D; Lee TD; Moore J; Manning T; Kunimoto D; LeBlanc D; Johnson JA; Gray CA
Can J Microbiol; 2010 Jun; 56(6):487-94. PubMed ID: 20657619
[TBL] [Abstract][Full Text] [Related]
74. Bioactivity-guided isolation of ethyl-p-methoxycinnamate, an anti-inflammatory constituent, from Kaempferia galanga L. extracts.
Umar MI; Asmawi MZ; Sadikun A; Atangwho IJ; Yam MF; Altaf R; Ahmed A
Molecules; 2012 Jul; 17(7):8720-34. PubMed ID: 22825623
[TBL] [Abstract][Full Text] [Related]
75. Extraction, characterization and evaluation of Kaempferia galanga L. (Zingiberaceae) rhizome extracts against acute and chronic inflammation in rats.
Jagadish PC; Latha KP; Mudgal J; Nampurath GK
J Ethnopharmacol; 2016 Dec; 194():434-439. PubMed ID: 27720847
[TBL] [Abstract][Full Text] [Related]
76. In Vitro Anti-mycobacterial Activity of Three Medicinal Plants of Lamiaceae Family.
Kazemian H; Heidari H; Yamchi JK; Zandi H; Taji A; Yazdani F; Hamzehloo G; Ghanavati R; Rahdar HA; Feizabadi MM
Recent Pat Antiinfect Drug Discov; 2018; 13(3):240-245. PubMed ID: 29952265
[TBL] [Abstract][Full Text] [Related]
77. In vitro activity of collinin isolated from the leaves of Zanthoxylum schinifolium against multidrug- and extensively drug-resistant Mycobacterium tuberculosis.
Kim S; Seo H; Mahmud HA; Islam MI; Lee BE; Cho ML; Song HY
Phytomedicine; 2018 Jul; 46():104-110. PubMed ID: 30097109
[TBL] [Abstract][Full Text] [Related]
78. In vitro efficacy of acetohydroxyacid synthase inhibitors against clinical strains of Mycobacterium tuberculosis isolated from a hospital in Beijing, China.
Dong M; Wang D; Jiang Y; Zhao L; Yang C; Wu C
Saudi Med J; 2011 Nov; 32(11):1122-6. PubMed ID: 22057598
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of the antimycobacterial activity of crude extracts and solvent fractions of selected Ethiopian medicinal plants.
Kahaliw W; Aseffa A; Abebe M; Teferi M; Engidawork E
BMC Complement Altern Med; 2017 Mar; 17(1):143. PubMed ID: 28274226
[TBL] [Abstract][Full Text] [Related]
80. Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis.
Bunalema L; Fotso GW; Waako P; Tabuti J; Yeboah SO
BMC Complement Altern Med; 2017 Feb; 17(1):89. PubMed ID: 28148252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
